[144] Wheeler Real Estate Investment Trust, Inc SEC Filing

Rhea-AI Filing Summary

Form 144 filed for MYT Netherlands Parent B.V. (NYSE: MYTE) discloses that insider Michael Kliger intends to sell up to 108,375 common shares on or about 07 July 2025 through Morgan Stanley Smith Barney. Based on the stated aggregate market value of $824,733.75, the proposed sale represents roughly 0.08 % of the 136.37 million shares outstanding.

The filing also lists significant prior activity under a Rule 10b5-1 trading plan. Over the last three months, Kliger executed approximately 1.23 million shares in 25 separate transactions, generating disclosed gross proceeds of more than $9 million (sum of line-item figures). This cumulative volume is about 0.9 % of shares outstanding.

Shares to be sold were recently acquired via (1) exercise of 62,396 stock options on 07 Jul 2025 and (2) vesting of 45,979 restricted stock units on 30 Jun 2025. The seller certifies no possession of undisclosed material adverse information and relies on the trading plan safe-harbor.

• Proposed sale size is modest in percentage terms but continues a sustained insider selling trend.
• Form 144 does not provide operational or earnings data; the disclosure focuses solely on share disposition.

Positive

• Use of Rule 10b5-1 plan suggests trades are pre-scheduled, lowering the risk of insider-information abuse.
• Sale equals only ~0.08 % of shares outstanding, limiting immediate dilution or price impact.

Negative

• Continued insider selling: roughly 1.34 million shares (≈1 % float) disclosed for sale in a three-month window, which can weigh on sentiment.
• Lack of offsetting insider buys may be interpreted as reduced management conviction.

Insights

Securities Analyst

TL;DR Insider continues sizable sales; modest new sale adds to 3-month total of 1.23 M shares.

The additional 108 k-share Form 144 is small individually but, when added to the 1.23 million shares already sold since April under a 10b5-1 plan, signals persistent liquidity harvesting by the CEO. While the combined 1.34 million shares equal just under 1 % of MYTE’s float—unlikely to move the market mechanically—the optical effect can pressure sentiment, especially absent offsetting insider purchases. No operational information accompanies this filing, so the trading pattern remains the key takeaway. I view the disclosure as incrementally negative for perception but not fundamentally disruptive.

Corporate Governance Expert

TL;DR Sales follow 10b5-1 protocol; governance risk limited, but optics still cautious.

The seller relies on a pre-established Rule 10b5-1 plan, which mitigates concerns about trading on undisclosed information. The representation that no material non-public information is held further reduces regulatory risk. However, steady off-loading by a key executive over multiple quarters can erode investor confidence in long-term alignment. The modest scale relative to float means governance red flags are low, yet boards often track cumulative selling trends as part of succession and retention planning.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Series B Convertible Preferred Stock	Raymond James & Associates 880 Carillon Parkway St. Petersburg FL 33716	14955	59820.00	3096018	07/03/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Series B Convertible Preferred Stock	01/03/2023	Shares received in lieu of interest payment	Issuer			817085	01/03/2023	Interest payment received

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Stilwell Activist Investments, L.P. 111 Broadway New York NY 10006	Series B Convertible Preferred Stock	05/27/2025	871	3484.00
Stilwell Activist Investments, L.P. 111 Broadway New York NY 10006	Series B Convertible Preferred Stock	06/04/2025	10338	41352.00
Stilwell Activist Investments, L.P. 111 Broadway New York NY 10006	Series B Convertible Preferred Stock	06/04/2025	2344	9376.00
Stilwell Activist Investments, L.P. 111 Broadway New York NY 10006	Series B Convertible Preferred Stock	06/04/2025	1492	5968.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many MYTE shares does Michael Kliger plan to sell in the new Form 144?

He intends to sell 108,375 common shares on or around 07 Jul 2025.

What is the market value of the proposed MYTE share sale?

The aggregate market value reported is $824,733.75.

How much has the insider already sold in the past three months?

Form 144 lists about 1.23 million shares sold between April and July 2025 under a 10b5-1 plan.

What percentage of MYTE’s outstanding shares do the planned sales represent?

The new 108 k-share block equals roughly 0.08 % of the 136.37 million shares outstanding.

Were the shares recently acquired or long-held?

Yes—62,396 shares came from option exercise and 45,979 from RSU vesting in late June–early July 2025.

Does the filing mention any undisclosed material information?

The signer certifies no knowledge of material adverse non-public information, satisfying Rule 144 requirements.